DOTA Conjugated JM21 derivative 7, CAS [[3033865-40-3]] Preis auf Anfrage

Artikelnummer: TGM-TP2658
Artikelname: DOTA Conjugated JM21 derivative 7, CAS [[3033865-40-3]] Preis auf Anfrage
Artikelnummer: TGM-TP2658
Hersteller Artikelnummer: TP2658
Alternativnummer: TGM-TP2658-10MG, TGM-TP2658-50MG
Hersteller: TargetMol
Kategorie: Biochemikalien
DOTA-Conjugated JM21 Derivative 7 (compound Ligand-7) is a CXCR4-targeting peptide derivative conjugated with DOTA, suitable for producing radioligands. Radiolabeled with 177Lu, this compound, referred to as 177Lu-DOTA, demonstrates superior CXCR4 tumor
Molekulargewicht: 1471.75
CAS Nummer: [3033865-40-3]
Formel: C66H114N22O16